BAC
Bank of America Corporation
BAC has the edge over IFS overall, supported by stronger fundamentals and stronger modeled upside.
IFS
Intercorp Financial Services Inc.
IFS trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
IFS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
IFS's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like IFS.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over IFS in the historical PE scenario, which offers more potential upside but is not a forecast.
IFS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.5x | $35.81 | -30% |
| Fair | 8.4x | $46.57 | -9.3% |
| Current | 9.3x | $51.36 | — |
| Expensive | 12x | $67.13 | +31% |
Historical ranges are pointers, not guarantees.
IFS's PE is 9.3x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over IFS on the outlook, with more favorable profitability expectations.
IFS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for IFS, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over IFS on earnings, with more consistent year-over-year improvement.
IFS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $5.52 | +12% |
| Q1 2026 | $5.49 | +33% |
| Q4 2025 | $5.06 | +51% |
| Q3 2025 | $5.10 | +81% |
| Q2 2023 | $4.08 | +8.2% |
| Q1 2023 | $3.88 | -9.6% |
| Q4 2022 | $4.22 | -8.5% |
| Q3 2022 | $3.93 | -20% |
IFS earned $5.52 per share over the past year, up 12% from the year before. Its recent earnings include one-off gains.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over IFS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over IFS on profitability, with a higher operating margin.
IFS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $710.7M | -26% |
| Q1 2026 | $899.1M | +32% |
| Q4 2025 | $374.5M | -44% |
| Q3 2025 | $641.3M | -1.9% |
| Q2 2025 | $956.4M | +44% |
| Q1 2025 | $680.6M | +12% |
| Q4 2024 | $668.2M | -1.8% |
| Q3 2024 | $653.5M | -0.2% |
IFS's revenue has slid since its 2025 peak: $711M last quarter, down 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 29% | +7.7 points |
| Q1 2026 | 25% | +1.1 points |
| Q4 2025 | 48% | +21 points |
| Q3 2025 | 26% | +5.2 points |
| Q2 2025 | 21% | +5.1 points |
| Q1 2025 | 24% | +15 points |
| Q4 2024 | 28% | +15 points |
| Q3 2024 | 21% | +9.5 points |
IFS's operating margin was 29% last quarter, up 7.7 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
IFS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $795.8M | +531% |
| Q1 2026 | -$63.9M | +$74.7M |
| Q4 2025 | $769M | +$1.1B |
| Q3 2025 | -$373.3M | -160% |
| Q2 2025 | $126.2M | +$383.2M |
| Q1 2025 | -$138.5M | -119% |
| Q4 2024 | -$341.8M | -$190M |
| Q3 2024 | $622.2M | +179% |
IFS has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over IFS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
IFS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -205K shares |
| 1 year | -1.3% | -1.4M shares |
| 3 years | -3.9% | -4.5M shares |
| 5 years | -3.9% | -4.5M shares |
| Available history | -4% | -4.6M shares |
IFS has 111M diluted shares, down 1.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $31.5M |
| Q1 2026 | $453,026 |
| Q4 2025 | $10.7M |
| Q3 2025 | $8.1M |
| Q2 2025 | $16.7M |
| Q1 2025 | $41.6M |
| Q4 2024 | $34.6M |
| Q3 2024 | $1.3M |
IFS spent $51M buying back its own shares over the past year, down 46% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
IFS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | -0.2x | Net Cash |
| Q3 2024 | -1.1x | Net Cash |
IFS has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
IFS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.1 | Neutral |
| Stochastic | 14.0 | Oversold |
IFS's weekly RSI is 48 (neutral) and its Stochastic is 14 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
IFS PE vs Financial Services Sector
| Metric | IFS | Sector median | Relative |
|---|---|---|---|
| PE | 9.3x | 13x | 29% below |
| PE % | 61 | 63 | 2 pts below |
IFS has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
IFS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $51.8 | 0.9% below |
| 20 week MA | $55.0 | 6.6% below |
| 50 week MA | $50.4 | 1.9% above |
| 100 week MA | $43.1 | 19% above |
| 200 week MA | $33.3 | 54% above |
IFS has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
IFS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $40.7 | $30.0 | -26% |
| 2021 | $30.0 | $25.5 | -15% |
| 2022 | $25.5 | $23.3 | -8.6% |
| 2023 | $23.3 | $22.0 | -5.9% |
| 2024 | $22.0 | $29.1 | +32% |
| 2025 | $29.1 | $42.9 | +48% |
| 2026 YTD | $42.9 | $51.4 | +20% |
IFS has the edge over BAC on returns for 2026, with the stronger performance.